Statistics

Total Visits

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation58

Select a period of time:

Number of views in the range

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation22

Views

Views
May 20250
June 20250
July 202516
August 20250
September 20252
October 20251
November 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil8
United States6
Argentina4
Canada1
United Kingdom1
Morocco1
Paraguay1
 

Top cities views

Views
Córdoba2
Asunción1
Dallas1
Guarujá1
Imbituba1
Merlo1
Oujda1
Pelotas1
Saint-Jean-sur-Richelieu1
Salvador1